NOTCH1 and head and neck squamous cell carcinoma: Thus, our data indicate that RARγ contributes to signaling through the Notch pathway and are consistent with the report that loss of expression and/or mutation of the tumor suppressor NOTCH1 or Notch signaling pathway genes account for ∼67% of human HNSCC cases that include OCSCC (23).